|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2003-8-22
|
|
pubmed:abstractText |
Prolongation of the QT interval is associated with an increased risk of arrhythmia, coronary heart disease (CHD), and mortality. Estrogens and androgens have been proposed as a causal factor in QT lengthening. We tested whether postmenopausal hormone replacement therapy was associated with prolonged QT intervals in a healthy population sample of women (mean age=54).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1047-2797
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
530-6
|
|
pubmed:dateRevised |
2008-6-23
|
|
pubmed:meshHeading |
pubmed-meshheading:12932629-Arteriosclerosis,
pubmed-meshheading:12932629-Cohort Studies,
pubmed-meshheading:12932629-Electrocardiography,
pubmed-meshheading:12932629-Estrogen Replacement Therapy,
pubmed-meshheading:12932629-Female,
pubmed-meshheading:12932629-Humans,
pubmed-meshheading:12932629-Long QT Syndrome,
pubmed-meshheading:12932629-Longitudinal Studies,
pubmed-meshheading:12932629-Middle Aged,
pubmed-meshheading:12932629-Prospective Studies,
pubmed-meshheading:12932629-United States
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
A prospective evaluation of the risk of QT prolongation with hormone replacement therapy: the atherosclerosis risk in communities study.
|
|
pubmed:affiliation |
Stanford Center for Research in Disease Prevention, Stanford University School of Medicine, Palo Alto, CA, USA. carnethon@northwestern.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Evaluation Studies
|
